Small Molecule Therapies for Rheumatoid Arthritis: Global Markets to 2022
Single User License: $2750Member Price: FREE
Report Highlights
The global small molecule therapies for rheumatoid arthritis market totaled $1.7 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 6.6% for the period of 2017-2022.
Report Includes
95 data tables
Country specific data and analysis for China, India, Japan, Australia, United Kingdom, Germany, France, Italy, Spain, Russia, USA, and Brazil
Identification of segments with high growth potential and their future applications
Explanation of major drivers and regional dynamics of the market and current trends within the industry
Detailed profiles of major vendors in the market, including AbbVie Inc., Amgen Inc., Bristol-Myers Squibb, F. Hoffmann-La Roche AG and Pfizer Inc.
Report Scope
This research report categorizes the small molecule therapies for rheumatoid arthritis market by product type. Product type include disease modifying anti-rheumatic drugs, non-steroidal anti-inflammatory drugs and corticosteroids.
Analyst Credentials
BCC Research analysts craft reference reports with a unique end noted referencing methodology, which allows users to cross reference and trace market numbers back to their source. These individuals are experts in secondary research and primary forecasting - compiling and layering existing data with their original research and analysis. The team has decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies
Small Molecule Therapies for Rheumatoid Arthritis: Global Markets to 2022
The global market for pain management will grow from nearly $36.1 billion in 2017 to $52.0 billion by 2022, with a compound annual growth rate (CAGR) of 7.6% for the period of 2017-2022.
The global market for generic drugs should reach $533 billion by 2021 from $352 billion in 2016 at a compound annual growth rate (CAGR) of 8.7%, from 2016 to 2021.
Paul Evers | Feb 2017
Share This Report
Custom Research - PHM195A
Download Report Overview - Small Molecule Therapies for Rheumatoid Arthritis: Global Markets to 2022
Complete the form below and we'll send you a private, secure link to download the Report Overview as a PDF.
